Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?
Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicine stockanalysis.com. The company’s name “Acrivon” is